Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Calcipotriene
Drug ID BADD_D00334
Description Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
Indications and Usage For the treatment of moderate plaque psoriasis in adults.
Marketing Status approved
ATC Code D05AX02
DrugBank ID DB02300
KEGG ID D01125
MeSH ID C055085
PubChem ID 49800068
TTD Drug ID D01QUS
NDC Product Code 0713-0318; 71052-476; 51862-376; 0781-7117; 0168-0400; 50383-732; 0115-1475; 40032-043; 58272-197; 73309-104; 51672-4154; 68462-310; 50222-260; 51407-605; 51862-512; 66993-878; 54239-005; 16714-763; 63415-0052; 51407-606; 66993-877; 68462-501; 51672-5278
UNII 143NQ3779B
Synonyms calcipotriene | calcipotriol | 1,24(OH)2-22-ene-24-cyclopropyl D3 | Psorcutan | Sorilux | PRI-2205 | heximar win care | Dovonex | Daivonex | MC 903 | MC-903
Chemical Information
Molecular Formula C27H42O4
CAS Registry Number 147657-22-5
SMILES CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C.O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site erythema08.02.01.001; 23.03.06.005; 12.07.01.001--Not Available
Application site pain12.07.01.004; 08.02.01.004--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Dermatitis23.03.04.002--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis23.11.04.003; 11.02.01.053--
Hypercalcaemia14.04.01.003; 05.04.01.002--
Hypersensitivity10.01.03.003--
Instillation site pain12.07.01.008; 08.02.01.008--Not Available
Pain08.01.08.004--
Paraesthesia23.03.03.094; 17.02.06.005--
Pruritus23.03.12.001--
Psoriasis23.03.14.002; 10.02.01.036--Not Available
Rash23.03.13.001--Not Available
Skin atrophy23.01.05.001--
Skin exfoliation23.03.07.003--Not Available
Skin hyperpigmentation23.05.01.003--
Skin irritation23.03.04.009--Not Available
Koebner phenomenon23.03.03.058--Not Available
The 1th Page    1    Total 1 Pages